Sort
15,842 grants matching “pancreatic cancer”
Macropinocytosis Inhibition as a Glutamine Mimetic Sensitization Strategy in Pancreatic Cancer
$565,933Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Integrative Molecular Profiling of Human Pancreatic Cancer
$565,875Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
$565,875Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
$565,804Nancy L Allbritton · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA
Acquisition of an IVIS Spectrum 2 for Localization and Quantification of Fluorescence and Bioluminescence in Live Animals
$565,727Purnima Bhanot · Rutgers Biomedical And Health Sciences · S10 · FY2025 · OD
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
$565,549Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2020 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
$565,439Timothy R Donahue · University Of California Los Angeles · R01 · FY2023 · CA
Project 1: Physical modeling and dynamics of tumor cell migration mechanics
$565,189David J Odde · University Of Minnesota · U54 · FY2016 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$565,118Shan Zha · Columbia University Health Sciences · R01 · FY2024 · CA
The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor
$564,851Aatur Dilip Singhi · University Of Pittsburgh At Pittsburgh · R37 · FY2025 · CA
Sialylation-dependent mechanisms driving pancreatic cancer progression
$564,739Susan L Bellis · University Of Alabama At Birmingham · U01 · FY2018 · CA
Project 2: Cell Migration in Mechanically Complex Microenvironments
$564,723Paolo Provenzano · University Of Minnesota · U54 · FY2019 · CA
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$564,655Alan Ashworth · University Of California, San Francisco · R01 · FY2018 · CA
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response
$564,647Theodore S Lawrence · University Of Michigan At Ann Arbor · U01 · FY2019 · CA
The Oral Mycobiome and Risk of Pancreatic Cancer
$564,544Jiyoung Ahn · New York University School Of Medicine · U01 · FY2024 · CA
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer
$564,526Rebekah White · University Of California, San Diego · R01 · FY2024 · CA
BD FACSAriaTM Fusion Fluoresence-Activated Cell Sorter
$564,512Carol E Schrader · Univ Of Massachusetts Med Sch Worcester · S10 · FY2020 · OD
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
$564,406Alison P Klein · Johns Hopkins University · R01 · FY2014 · CA
Multimeric Ligands for Targeting of Pancreatic Cancer
$564,312University Of Arizona · R33 · FY2005 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$564,229Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer
$564,115Kenneth P Olive · Columbia University Health Sciences · R01 · FY2023 · CA
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
$564,066Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
$563,735Mark R. Kelley · Indiana University Indianapolis · R01 · FY2019 · CA
Development of contrast agents to facilitate image-guided surgery
$563,640Lacey R McNally · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
$563,237Wendell A Lim · University Of California, San Francisco · R01 · FY2025 · CA